TARS earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -50.51. Updated 2026-07-23.
Tarsus Pharmaceuticals (TARS) Research Hub
Tarsus Pharmaceuticals (TARS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 79.31 USD (-4.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -50.51, market cap 2.48B. This hub links to the full technical, earnings and options research available for TARS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 79.31 USD (-4.18%) |
| 52-week range | 53.89 USD – 91.53 USD |
| Trend regime | Range |
| 14-day RSI | 66.4 (Bullish) |
| Trailing P/E | -50.51 |
| Market cap | 2.48B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TARS
Covered Call on TARS: how it works, illustrative setup around the real 79.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TARS: how it works, illustrative setup around the real 79.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TARS: how it works, illustrative setup around the real 79.31 USD price, max profit/loss, breakeven and when to use it. Educational.
TARS technical analysis: range, last 79.31 USD, RSI 66.4, 52w range 53.89 USD–91.53 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TARS in?
Tarsus Pharmaceuticals (TARS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TARS in an uptrend or downtrend?
As of 2026-09-11, TARS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TARS's trailing P/E ratio?
TARS's trailing P/E is -50.51, with a market cap of 2.48B. See the earnings research page for full valuation detail.
When does TARS next report earnings?
TARS is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.21 USD.